Ingo Mellinghoff

Dr. Mellinghoff is a physician-scientist whose research focuses on the characterization of aberrant signaling pathways in cancer and new precision medicine paradigms to target these pathways. Dr. Mellinghoff’s work has led to practice-changing advances in the treatment of central nervous system cancer. He is an elected member of the American Society of Clinical Investigation and the Association of American Physicians. Dr. Mellinghoff currently serves as Chair of the Department of Neurology and the Evnin Family Chair in Neuro-Oncology at Memorial Sloan Kettering Cancer Center.